Annual Lung SPORE Workshop (Abstract Submission)
75 submissions
| Created | First Name | Last Name | Phone | Select a Session Topic | Abstract Title | First Author First Name | First Author Last Name | Affiliation | List of Additional Authors | Your Abstract Submission | Upload Abstract | Special Characters Included? | Abstract Review Status | Upload Poster | Poster Uploaded | Operations | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thu, 03/14/2024 - 01:26 | Alexandra | Potter | apotter8@mgh.harvard.edu | 2538829777 | Session 2: Health Disparities in Lung Cancer | The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility | Alexandra | Potter | Massachusetts General Hospital |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
| Sun, 03/10/2024 - 20:25 | Alice | Berger | ahberger@fredhutch.org | 2066676281 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Systematic discovery of osimertinib resistance variants using CRISPR prime editing | Alice | Berger | Fred Hutch | Abstract_Submission.pdf | No | Approved to be a Speaker | |||||
| Mon, 03/11/2024 - 09:20 | Andrey | Ivanov | andrey.ivanov@emory.edu | (404) 727-6343 | Session 6: Cancer Biology | The AVERON Notebook: a computational approach to druggable cancer dependencies enabled by mutant-directed protein-protein interactions. | Hongyue (Nicole) | Chen | Emory University |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
| Mon, 03/11/2024 - 13:09 | Arnaud | Augert | arnaud.augert@yale.edu | Session 4: Small Cell Lung Cancer | The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC | Arnaud | Augert | Yale University | Abstract_Submission.pdf | No | Approved to be a Speaker | ||||||
| Mon, 03/11/2024 - 14:46 | Austin | Draycott | austin.draycott@yale.edu | 3475969754 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer | Austin | Draycott | Yale University |
|
Abstract_Submission.pdf | DUS2_Lung_SPORE_Abstract.docx14.37 KB
|
No | Approved to be a Poster Presenter | |||
| Thu, 02/29/2024 - 15:57 | Bluma | Lesch | bluma.lesch@yale.edu | 203-737-1074 | Session 6: Cancer Biology | Mechanisms of epigenetic sensitization to lung cancer risk | Benjamin | Walters | Yale University |
|
Abstract_Submission.pdf | 240228_lesch_spore_abstract.docx13.43 KB
|
No | Approved to be a Poster Presenter | |||
| Fri, 03/08/2024 - 19:37 | Boning | Gao | boning.gao@utsouthwestern.edu | 2146484915 | Session 6: Cancer Biology | New human cell line models for the study of pathogenesis of SARS-CoV-2 infection | Boning | Gao | UT Southwestern |
|
Abstract_Submission.pdf | Gao_UT Southwester_Sesson#6.docx15.37 KB
|
No | Approved to be a Poster Presenter | |||
| Sun, 03/10/2024 - 20:03 | Caro | Kravitz | caro.kravitz@yale.edu | Session 6: Cancer Biology | The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis | Caro | Kravitz | Yale University |
|
Abstract_Submission.pdf | Kravitz_Yale_Session_6.docx16.55 KB
|
No | Approved to be a Poster Presenter | ||||
| Sun, 03/10/2024 - 03:47 | Catherine | Meador | cbmeador@mgh.harvard.edu | 9192603477 | Session 4: Small Cell Lung Cancer | Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling | Catherine | Meador | Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
| Wed, 04/03/2024 - 17:40 | Cecil | Han | ch1182@georgetown.edu | 2026878634 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies, Session 6: Cancer Biology | The emerging role of deubiquitinating enzyme USP13 in lung cancer plasticity | Juntae | Kwon | Georgetown University School of Medicine | Abstract_Submission.pdf | No | Approved to be a Speaker | |||||
| Mon, 03/11/2024 - 13:33 | Darin | Dolezal | darin.dolezal@yale.edu | 203-584-4276 | Session 6: Cancer Biology | Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer | Darin | Dolezal | Yale School of Medicine - Department of Pathology |
|
Abstract_Submission.pdf | Yes | Approved to be a Poster Presenter | ||||
| Sun, 03/10/2024 - 20:25 | Diane | Yang | dyang17@mgh.harvard.edu | Session 6: Cancer Biology | Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers | Diane | Yang | Department of Pathology, Massachusetts General Hospital, Boston, MA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | |||||
| Mon, 03/11/2024 - 10:46 | Don | Nguyen | don.nguyen@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis | Don | Nguyen | Yale School of Medicine | Abstract_Submission.pdf | Nguyen SPORE Workshop 2024.docx18.17 KB
|
No | Approved to be a Speaker | |||||
| Mon, 03/11/2024 - 14:55 | Elda | Railey | erailey@researchadvocacy.org | 2146839937 | Session 6: Cancer Biology | Identifying Unique Challenges and Opportunities in Incorporating Patient Advocates into the Lung Cancer SPORE Program | Elda | Railey | UTSWMC/MDACC Lung SPORe and Research Advocacy Network |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
| Mon, 03/11/2024 - 12:15 | Elisabeth | Martinez | elisabeth.martinez@utsouthwestern.edu | Session 4: Small Cell Lung Cancer | Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer | Aiden | Nguyen | UTSW |
|
Abstract_Submission.pdf | Martinez_UTSW_#4.docx14.1 KB
|
No | Approved to be a Speaker | ||||
| Mon, 03/11/2024 - 06:48 | Elliott | Brea | elliott_brea@dfci.harvard.edu | 8479221042 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings | Elliott | Brea | DFCI |
|
Abstract_Submission.pdf | Brea_DFCI_1.docx17.97 KB
|
No | Approved to be a Poster Presenter | |||
| Mon, 03/11/2024 - 13:12 | Esra | Akbay | esra.akbay@utsouthwestern.edu | 2146484159 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models | Esra | Akbay | UT Southwestern Medical Center | Abstract_Submission.pdf | Akbay_UTSW_Session 1.docx15.43 KB
|
No | Approved to be a Poster Presenter | ||||
| Mon, 03/11/2024 - 14:56 | Florian | Fintelmann | fintelmann@mgh.harvard.edu | 6178490063 | Session 5: Early Detection and Screening | Significance of image acquisition parameters for Sybil’s ability to predict future lung cancer risk on low-dose chest computed tomography | Judit | Simon | MGH |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
| Mon, 03/11/2024 - 09:40 | Francisco | Exposito | francisco.exposito@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer | Francisco | Exposito | Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | |||||
| Mon, 03/11/2024 - 13:21 | Hari Shankar | Sunil | harishankar.sunil@utsouthwestern.edu | 9727302166 | Session 3: Immuno-oncology, Session 6: Cancer Biology | Transmembrane Serine Protease TMPRSS11B promotes tumorigenesis in lung squamous cell carcinoma through enhanced lactate export and modulation of the tumor microenvironment | Hari Shankar | Sunil | UT Southwestern Medical Center |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter |